A groundbreaking study in the US has revealed that artificial intelligence is capable of spotting pancreatic, lung, and colorectal cancers as much as four years ahead of human doctors recognizing any irregularities. The AI detected risk indicators in standard blood tests and imaging that were not visible to medical professionals. This research is currently undergoing FDA review, and numerous major healthcare systems in the US have initiated pilot programs.
